Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors that remains unauthorised by the MHRA and EMA
Standard TB-500 protocol: Loading phase (Weeks 1-4): 5mg twice weekly (Monday/Thursday) Total per week: 10mg Total for loading: 40mg (8 vials of 5mg) Maintenance phase (Weeks 5-12): 2-5mg once weekly Total per week: 2-5mg Total for maintenance: 16-40mg (3-8 vials) Example: 5mg vial + 2ml water = 2,500mcg/ml 5mg dose (5,000mcg) = draw 2.0ml (full vial) 2.5mg dose = draw 1.0ml TB-500 doses are MUCH larger than BPC-157
20 : 141158 Benga G, Holmes RP
Improve Sleep Quality Getting 79 hours of quality beauty sleep each night naturally boosts GLP-1 production by aligning your circadian rhythm, enhancing vagus nerve activity, and supporting a healthy gut microbiome that triggers GLP-1 release (St-Onge et al., 2016)

Conditions associated with elevated B12 levels include: Liver disease : Hepatocellular damage releases stored B12 into circulation, with levels correlating with disease severity in conditions such as cirrhosis, hepatitis, and hepatocellular carcinoma Renal impairment : Reduced kidney function decreases B12 clearance, leading to accumulation Haematological malignancies : Myeloproliferative disorders, acute leukaemia, and polycythaemia vera can elevate B12 through increased production of B12-binding proteins (transcobalamins) Solid tumours : Certain cancers, particularly those affecting the liver or gastrointestinal tract, may elevate B12 levels A specific concern relates to cyanocobalamin in patients with Leber's hereditary optic neuropathy , a rare mitochondrial disorder